Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2012PLoS ONEOpen Access

Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

TITakehiro IchikawaFSFumiaki SatoSumitomo Dainippon Pharma (Japan)KTKazuya TerasawaKyoto University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ichikawa et al. (2012) studied this question.

synapsesocial.com/papers/6a974fb1824c98cfb78bd1c8https://doi.org/10.1371/journal.pone.0031422
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cyclin E2, a Novel G1 Cyclin That Binds Cdk2 and Is Aberrantly Expressed in Human Cancers1999 · 177 citations
  2. 2HER2-targeting Antibodies Modulate the Cyclin-dependent Kinase Inhibitor p27Kip1 via Multiple Signaling Pathways2004 · 146 citations
  3. 3MicroRNAs modulate the chemosensitivity of tumor cells2008 · 367 citations
  4. 4Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin2010 · 334 citations